RxDoctor Payments Data

Vajira Gunawardane, MD

Pain Management · Fulton, MDNPI 1447294269

Payments from drug & device makers

$22,856in general payments, 2019–2025

Across 1,192 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Biogen$1K
  • Pfizer$1K
  • Lundbeck LLC$1K
  • Lilly USA, LLC$1K
  • plus $10K from 54 others

What the payments were for

  • Speaking & faculty fees$260%
  • Food & beverage$22,829100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)412$5,864
Teva Pharmaceuticals USA, Inc.68$1,818
Biogen70$1,392
Pfizer66$1,181
Lundbeck LLC61$1,149
Lilly USA, LLC45$1,091
UCB, Inc.42$1,003
Biohaven Pharmaceutical Holding Company Ltd.23$812
Eisai Inc.27$744
Argenx US, Inc.29$730
Johnson & Johnson57$584
AstraZeneca23$575
Amgen(2 entities)14$462
Kyowa Kirin, Inc.17$429
Boston Scientific10$425
Bausch Health US, LLC29$393
Akcea Therapeutics, Inc.12$370
Biohaven Pharmaceuticals, Inc.11$305
Catalyst Pharmaceuticals, Inc.14$304
Arbor Pharmaceuticals, Inc.27$285
Genentech USA, Inc.8$204
Upsher-smith Laboratories LLC10$187
Axsome Therapeutics, Inc.6$174
ANI Pharmaceuticals, Inc.5$158
Avion Pharmaceuticals12$144
Acorda Therapeutics, Inc7$140
Vanda Pharmaceuticals Inc.4$112
Currax Pharmaceuticals LLC8$109
Sandoz4$107
CSL Behring4$106
GE HealthCare4$105
Medtronic1$90
Scilex Pharmaceuticals Inc.4$86
Amneal Pharmaceuticals LLC3$74
Grifols USA, LLC3$69
Springworks Therapeutics, Inc.3$68
Azurity Pharmaceuticals, Inc.3$64
Mallinckrodt Hospital Products Inc.2$57
Avanir Pharmaceuticals, Inc.3$55
Takeda Pharmaceuticals U.S.A., Inc.2$53
Alnylam Pharmaceuticals Inc.2$50
Livanova USA, Inc.2$49
Biotronik NRO, Inc.2$48
Tersera Therapeutics LLC3$47
Almatica Pharma LLC2$47
Tanabe Pharma America, Inc.2$43
Supernus Pharmaceuticals, Inc.3$41
Assertio Therapeutics, Inc.2$41
Adamas Pharmaceuticals, Inc.2$39
Jazz Pharmaceuticals Inc.1$37
Neurocrine Biosciences, Inc.1$30
Daiichi Sankyo Inc.2$29
Galderma Laboratories, L.p.2$27
Banner Life Sciences, LLC2$27
Octapharma USA, Inc.1$26
Biomarin Pharmaceutical Inc.1$25
Pacira Pharmaceuticals Incorporated1$24
Impel Pharmaceuticals Inc.1$22
Merz Pharmaceuticals, LLC1$22
Impel Pharmaceuticals LLC1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain management providers in Marylandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$304,932
Medicare patients
398
Services billed
3,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin25$350
Cyclobenzaprine Hcl16$287
Oxycodone Hcl13$211
Meloxicam12$41

Paid to pharmacies, not to this prescriber.

Other pain management in Fulton

Where these figures come from

Is this you, or does something look wrong? →